Christopher P. Kiritsy - 02 Sep 2026 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Reporting relationship: Director
Issuer ticker: PVLA
Reported as of: 02 Sep 2026
Net transaction value: -$49,141
SEC form: 4
Accepted by SEC: 04 Sep 2026, 16:05:10 UTC
Prior SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen A. McGowan, Attorney-in-Fact

Key filing fact

Christopher P. Kiritsy filed Form 4 for PALVELLA THERAPEUTICS, INC. (PVLA) on 04 Sep 2026.

Key facts

This page summarizes Christopher P. Kiritsy's Form 4 filing for PALVELLA THERAPEUTICS, INC. (PVLA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 12 Jun 2026.
Current net transaction value: -$49,141.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001261156 Primary reporting owner

KIRITSY CHRISTOPHER P

Relationship: Director
Address: C/O PALVELLA THERAPEUTICS, INC., 353 W. LANCASTER AVENUE, SUITE 200, WAYNE
Signature: /s/ Kathleen A. McGowan, Attorney-in-Fact
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PVLA transaction

Common Stock

Options Exercise

Transaction value
Shares: +313
Change %: +125%
Price: $127.20^*
Shares after: 563
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1

PVLA transaction

Common Stock

Sale

Transaction value: $49,141
Shares: -313
Change %: -56%
Price: $157.00
Shares after: 250
Date: 02 Sep 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PVLA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -313
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 313
Exercise price: $127.20
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024.

Footnote F2

The stock option is fully vested.